The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' (NBIX.O) , opens new tab Ingrezza drug to treat movement disorders associated with ...

The company received a groundbreaking FDA approval for its latest drug-eluting scaffold, designed to help reopen arteries in the legs that have become clogged below the knee. The Esprit BTK System ...

opens new tab said on Monday the U.S. FDA has approved its therapy to treat ... disease priority review voucher, which allows a drug developer to expedite the review process of its product even ...

(RTTNews) - The U.S. Food and Drug Administration has approved INGREZZA Sprinkle (valbenazine) capsules, a new oral granules formulation of INGREZZA (valbenazine) capsules prescribed for the ...

(RTTNews) - Labcorp (LH) announced the FDA has approved its nAbCyte Anti-AAVRh74var HB-FE Assay, a companion diagnostic to determine patient eligibility for treatment with BEQVEZ, Pfizer's ...

FDA Approves Clobazam Add-On for Lennox Syndrome The benzodiazepine is already available in 100 other countries, marketed under different brand names. News, October 24, 2011 Orphan Drug Status for ...

On April 29, 2024, The US Food and Drug Administration (FDA) has accepted a Supplemental New Drug Application for tapinarof cream, 1%, for the topical treatment of atopic dermatitis in adults and ...

In the US, X4 is planning the commercial launch of the capsules through its pharmacy partner PANTHERx Rare. Credit: NTshutterth/Shutterstock.com. The US Food and Drug ...

Apart from Eylea, profits from asthma drug Dupixent’s sales act as a primary growth driver ... Regeneron developed a higher dose of the drug. In August 2023, the FDA finally approved aflibercept 8 mg ...

The first-quarter 2024 reporting cycle of the Medical sector is currently in full swing. The sector mainly comprises pharma/biotech and medical device companies. With many pharma and biotech ...